Global Ovarian Cancer Treatment Drugs Market Report By Chemotherapy Drugs (Carboplatin, Cisplatin, Docetaxel, Paclitaxel, Other Medication), End User (Hospitals, Ambulatory Surgical Centers, Clinics) And By Regions - Industry Trends, Size, Share, Growth, Estimation and Forecast, 2018-2025
ID:VMR11210417
January 2019
Report Formats:

As per this study, the Global Ovarian Cancer Treatment Drugs Market was valued USD X.XX MN (by revenue) in 2018 and is anticipated to reach USD X.XX MN by 2025 with a CAGR of X.X%.

Ovarian Cancer is a dreadful type of cancer found in women where abnormal growth of cells is experienced in the ovaries. Ovarian Cancer is caused due to mutagenic changes in the DNA. Genetics also play important role in this type of disease. Ovarian Cancer is regarded as one of the most common types in women. According to the American Cancer Society, the risk of developing this type of cancer in women is 1 out of 75. Ovarian Cancer is developed mostly at old age around 55 in women. Some of the symptoms of Ovarian Cancer are a loss of appetite, pelvic ache, and abdominal puffiness.
 
Market Dynamics
 
The increasing prevalence of ovarian cancer, an increase in healthcare expenditure and increased government funding are some of the key factors driving the growth for global ovarian cancer treatment drugs market. On the other hand, high investments in research and expiration of patents of several leading drugs are some of the factors that restrain the global ovarian treatment drugs market. Whereas, new treatments are continually being explored as researchers use genetic testing and genomic sequencing to better understand attributes of ovarian cancer that can be targeted with drugs and this factor could be the opportunity for the ovarian cancer treatment drugs.
 
This detailed market study is centered on the data obtained from multiple sources and is analyzed using numerous tools including porter’s five forces analysis, market attractiveness analysis and value chain analysis. These tools are employed to gain insights of the potential value of the market facilitating the business strategists with the latest growth opportunities. Additionally, these tools also provide a detailed analysis of each application/product segment in the global market of ovarian cancer treatment drugs.
 
Market Segmentation
 
The broad ovarian cancer treatment drugs market has been sub-grouped into chemotherapy drugs and end-user. The report studies these subsets with respect to the geographical segmentation. The strategists can gain a detailed insight and devise appropriate strategies to target specific market. This detail will lead to a focused approach leading to identification of better opportunities.
 
By Chemotherapy Drugs

  • Carboplatin
  • Cisplatin
  • Docetaxel
  • Paclitaxel
  • Other Medication
 
By End User
  • Hospitals
  • Ambulatory Surgical Centers
  • Clinics
 
Regional Analysis
 
Furthermore, the report comprises of the geographical segmentation which mainly focuses on current and forecast demand for ovarian cancer treatment drugs in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The report further focuses on demand for individual application segments in all the regions.
 
Europe Ovarian Cancer Treatment Drugs Market By Revenue (USD MN)
 
Europe Ovarian Cancer Treatment Drugs Market By Revenue
 
The report also covers detailed competitive landscape including company profiles of key players operating in the global market. The key players in the Ovarian Cancer Treatment Drugs market include Aetera Zenteris Inc., Bristol Myers Squibb Company, Boehringer Ingelheim GmbH, Eli Lilly and Company, F. Hoffman-La Roche Ltd, GlaxoSmithKline plc, Genentech Inc., Janssen Pharmaceuticals, Inc., Novogen, Inc. An in-depth view of the competitive outlook includes future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other developments with information in terms of H.Q.
 

METHODOLOGY:
 
A combination of primary and secondary research has been used to determine the market estimates and forecasts. Sources used for secondary research include (but not limited to) Paid Data Sources, Company Websites, Technical Journals, Annual Reports, SEC Filings and various other industry publications. Specific details on methodology used for this report can be provided on demand.

1. INTRODUCTION

  • Introduction To Ovarian Cancer Treatment Drugs
  • Report Description
    • Objectives Of The Study
    • Assumptions
  • Research Scope
  • Research Methodology
    • Data Source
 
2. EXECUTIVE SUMMARY
  • Market Highlight
  • Global Ovarian Cancer Treatment Drugs Market: Snapshot
 
3. MARKET ANALYSIS
  • Drivers
  • Restraints
  • Opportunities
  • Porter’s Five Forces Analysis
  • Value Chain Analysis
 
4. OVARIAN CANCER TREATMENT DRUGS MARKET ANALYSIS BY CHEMOTHERAPY DRUG
  • Ovarian Cancer Treatment Drugs Market In Carboplatin
  • Ovarian Cancer Treatment Drugs Market In Cisplatin
  • Ovarian Cancer Treatment Drugs Market In Docetaxel
  • Ovarian Cancer Treatment Drugs Market In Paclitaxel
  • Ovarian Cancer Treatment Drugs Market In Other Medication
 
5. OVARIAN CANCER TREATMENT DRUGS MARKET ANALYSIS BY END USER
  • Ovarian Cancer Treatment Drugs Market In Hospitals
  • Ovarian Cancer Treatment Drugs Market In Ambulatory Surgical Centers
  • Ovarian Cancer Treatment Drugs Market In Clinics
 
6. OVARIAN CANCER TREATMENT DRUGS MARKET ANALYSIS BY GEOGRAPHY
  • North America (NA)
    • North America Market Estimates
    • North America Market Estimates By Country
    • United States (U.S.) Market Estimates By Segments
    • Rest Of North America Market Estimates By Segments
  • Europe (EU)
    • Europe Market Estimates
    • Europe Market Estimates By Country
    • United Kingdom (UK) Market Estimates By Segments
    • Germany Market Estimates By Segments
    • France Market Estimates By Segments
    • Rest Of Europe Market Estimates By Segments
  • Asia Pacific (APAC)
    • Asia Pacific Market Estimates
    • Asia Pacific Market Estimates By Country  
    • China Market Estimates By Segments
    • Japan Market Estimates By Segments
    • India Market Estimates By Segments
    • Rest Of Asia Pacific Market Estimates By Segments  
  • Latin America (LA)   
    • Latin America Market Estimates
    • Latin America Market Estimates By Country
    • Brazil Market Estimates By Segments
    • Rest Of Latin America Market Estimates By Segments
  • Middle East And Africa (MEA)   
    • Middle East And Africa Market Estimates
    • Middle East And Africa Market Estimates By Country
    • Middle East Market Estimates By Segments
    • Africa Market Estimates By Segments
 
7. COMPETITIVE LANDSCAPE OF THE OVARIAN CANCER TREATMENT DRUGS COMPANIES
  • Market Competition
  • Partnerships/Collaborations/Agreements
  • Mergers And Acquisitions
  • New Product Launches
  • Other Developments
 
8. COMPANY PROFILES OF THE OVARIAN CANCER TREATMENT DRUGS INDUSTRY (Company Overview, Financial, Major Products & Recent Development)
  • Aetera Zenteris Inc.
  • Bristol Myers Squibb Company
  • Boehringer Ingelheim GmbH
  • Eli Lilly and Company
  • F. Hoffman-La Roche Ltd
  • GlaxoSmithKline plc
  • Genentech Inc.
  • Janssen Pharmaceuticals, Inc.
  • Novogen, Inc.
 
* Tentative TOC
 
LIST OF TABLES
 
Table 1.  Market Highlights Of Ovarian Cancer Treatment Drugs
Table 2.  Global Ovarian Cancer Treatment Drugs Market By Chemotherapy Drugs
Table 3.  Global Ovarian Cancer Treatment Drugs Market By End-User
Table 4.  Global Ovarian Cancer Treatment Drugs Market By Geography
Table 5.  North America Ovarian Cancer Treatment Drugs Market
Table 6.  Europe Ovarian Cancer Treatment Drugs Market
Table 7.  Asia Pacific Ovarian Cancer Treatment Drugs Market
Table 8.  Latin America Ovarian Cancer Treatment Drugs Market
Table 9.  Middle East And Africa Ovarian Cancer Treatment Drugs Market 
Table 10. Partnership/Collaboration/Agreements
Table 11. Mergers And Acquisitions
Table 12. New Product Development
Table 13. Other Developments
  
LIST OF FIGURES
 
Fig. 1.     Market Segmentation Of Ovarian Cancer Treatment Drugs Market 
Fig. 2.     Top-Down Approach   
Fig. 3.     Bottom-Up Approach   
Fig. 4.     Market Highlights Of Ovarian Cancer Treatment Drugs
Fig. 5.     Porter’s Five Forces Analysis
Fig. 6.     Value Chain Analysis
Fig. 7.     Global Ovarian Cancer Treatment Drugs Market By Chemotherapy Drugs
Fig. 8.     Global Ovarian Cancer Treatment Drugs Market By End-User
Fig. 9.     Global Ovarian Cancer Treatment Drugs Market By Geography
Fig. 10.   North America Ovarian Cancer Treatment Drugs Market
Fig. 11.   Europe Ovarian Cancer Treatment Drugs Market
Fig. 12.   Asia Pacific Ovarian Cancer Treatment Drugs Market
Fig. 13.   Latin America Ovarian Cancer Treatment Drugs Market
Fig. 14.   Middle East And Africa Ovarian Cancer Treatment Drugs Market
Fig. 15.   Market Share Of Ovarian Cancer Treatment Drugs Companies
Fig. 19.   Recent Developments In Ovarian Cancer Treatment Drugs Industry
 
 
* Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.  

Objectives of Study

  • Define and measure the global market
  • Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
  • Analyze and identify major market trends along with the factors driving or inhibiting the market growth
  • Study the company profiles of the major market players with their market share
  • Analyze competitive developments

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Why Choose Us

Client First Policy
Excellent Quality
Robust After Sales Support
24/7 Email Support

Clients

Testimonials